$2.06
Immix is a biotechnology business based in the US. Immix shares (IMMX) are listed on the NASDAQ and all prices are listed in US Dollars. Immix employs 14 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Immix Biopharma stock
How to buy Immix stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IMMX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Immix stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Immix stock price (NASDAQ: IMMX)
Use our graph to track the performance of IMMX stocks over time.Immix shares at a glance
Latest market close | $2.10 |
---|---|
52-week range | $1.55 - $7.75 |
50-day moving average | $2.14 |
200-day moving average | $3.48 |
Wall St. target price | $7.00 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.93 |
Is it a good time to buy Immix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Immix price performance over time
Historical closes compared with the close of $2.1 from 2024-07-23
1 week (2024-07-17) | -3.67% |
---|---|
1 month (2024-06-24) | -7.89% |
3 months (2024-04-24) | -1.41% |
6 months (2024-01-24) | -55.13% |
1 year (2023-07-24) | 1.45% |
---|---|
2 years (2022-07-22) | -14.29% |
3 years (2021-07-20) | N/A |
5 years (2019-07-20) | N/A |
Immix financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -50.49% |
Return on equity TTM | -93.62% |
Profit margin | 0% |
Book value | $1.06 |
Market Capitalization | $54.9 million |
TTM: trailing 12 months
Immix share dividends
We're not expecting Immix to pay a dividend over the next 12 months.
You may also wish to consider:
- Science Applications International Corporation Common Stock (SAIC.US) (1.22% forward annual dividend yield)
Immix share price volatility
Over the last 12 months, Immix's shares have ranged in value from as little as $1.55 up to $7.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Immix's is 0.165. This would suggest that Immix's shares are less volatile than average (for this exchange).
To put Immix's beta into context you can compare it against those of similar companies.
- Ribbon Communications (RBBN.US): 1.079
- CACI International (CACI.US): 0.918
- Science Applications International Corporation Common Stock (SAIC.US): 0.681
Immix overview
Immix Biopharma, Inc. , a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc. , was incorporated in 2012 and is headquartered in Los Angeles, California.
Frequently asked questions
nullWhat percentage of Immix is owned by insiders or institutions?
Currently 41.597% of Immix shares are held by insiders and 20.469% by institutions. How many people work for Immix?
Latest data suggests 14 work at Immix. When does the fiscal year end for Immix?
Immix's fiscal year ends in December. Where is Immix based?
Immix's address is: 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 What is Immix's ISIN number?
Immix's international securities identification number is: US45258H1068
More guides on Finder
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question